Article 16 Dec 2022 How To Effectively Use Patent Counsel To Navigate The USPTO's Duty Of Candor Guidance Regarding FDA Submissions United States IP
Article 04 Aug 2022 Coherus Scores First Interchangeable Biosimilar Approval For Lucentis® United States Healthcare
Article 16 Mar 2022 How The U.S. Compares To Europe On Biosimilar Approvals And Products In The Pipeline Updated March 14, 2022 Worldwide Healthcare